Immunocyt test improves the diagnostic accuracy of urinary cytology: Results of a French multicenter study

Journal of Urology

Volumn 169, Issue 3, 2003, Pages 921-924

  Pfister, Christian ^a   Chautard, Denis ^b   Devonec, Marian ^b   Perrin, Paul ^b   Chopin, Dominique ^b   Rischmann, Pascal ^b   Bouchot, Olivier ^b   Beurton, Daniel ^b   Coulange, Christian ^b   Rambeaud, Jean Jacques ^b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Antibodies, monoclonal; Bladder neoplasms; Cystoscopy; Fluorescence

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FRANCE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE CYTOLOGY;

EID: 0037364526     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000048983.83079.4c     Document Type: Article

References (20)

1. Parmar, M. K. B., Freedman, L. S., Hargreave, T. B. and Tolley, D. A.: Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol, 142: 284, 1989
2. Kurth, K. H., Denis, L., Bouffioux, C., Sylvester, R., Debruyne, F. M., Pavone-Macaluso, M. et al: Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer, 31A: 1840, 1995
3. Lokeshwar, V. B. and Soloway, M. S.: Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol, 165: 1067, 2001
4. Pode, D., Shapiro, A., Wald, M., Nativ, O., Laufer, M. and Kaver, I.: Noninvasive detection of bladder cancer with the BTA stat test. J Urol, 161: 443, 1999
5. Serretta, V., Lo Presti, D., Vasile, P., Gange, E., Esposito, E. and Menozzi, I.: Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients. Urology, 52: 793, 1998
6. Sanchez-Carbayo, M., Herrero, E., Megias, J., Mira, A., Espasa, A., Chinchilla, V. et al: Initial evaluation of UBC as a tumor marker for bladder cancer. J Urol, 161: 1110, 1999
7. Ozen, H. and Hall, M. C.: Bladder cancer. Curr Opin Oncol, 12: 255, 2000
8. Fradet, Y. and Lockhart, C,: Performance characteristics of a new monoclonal antibody test for bladder cancer. Immunocyt Canad J Urol, 4: 400, 1997
9. Mian, C., Pycha, A., Wiener, H., Haitel, A., Lodde, M. and Marberger, M.: Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract. J Urol, 161: 1486, 1999
10. Epstein, J. I., Amin, M. B., Reuter, V. R. and Mostofi, F. K.: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 22: 1435, 1998
11. Gregoire, M., Fradet, Y., Meyer, F., Têtu, B., Bois, R., Bedard, G. et al: Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors, J Urol, 157: 1660, 1997
12. Saad, A., Hanbury, D. C., McNicholas, T. A., Boustead, G. B. and Woodman, A. C.: The early detection and diagnosis of bladder cancer: a critical review of the options. Eur Urol, 39: 619, 2001
13. Nam, R. K., Redelmeier, D. A., Spiess, P. E., Sampson, H. A., Fradet, Y, and Jewett, M. A. S.: Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis. J Urol, 163: 752, 2000
14. Wiener, H. G., Mian, Ch., Haitel, A., Psycha, A., Schatzl, G. and Marberger, M.: Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol, 159: 1876, 1998
15. Kriegmair, M., Zaak, D., Stepp, H., Stepp, H., Baumgartner, R., Knuechel, R. et al: Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur Urol, 36: 386, 1999
16. Olsson, H. and Zackrisson, B.: ImmunoCytTM: a useful method in the follow-up protocol for patients with urinary bladder carcinoma. Scand J Urol Nephrol, 35: 280, 2001
17. Vriesema, J. L., Atsma, F., Kiemeney, L. A., Peelen, W. P., Witjes, J. A. and Schalken, J. A.: Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence. Urology, 58: 367, 2001
18. Clark, K. R. and Higgs, M. J.: Urinary infection following outpatient flexible cystoscopy. Br J Urol, 66: 503, 1990
19. Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C. and Fair, W. R.: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol, 158: 62, 1997
20. Lodde, M., Mian, C., Wiener, H., Haitel, A., Pycha, A. and Marberger, M.: Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report. Urology, 58: 362, 2001